BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21468523)

  • 1. Clinical and molecular aspects of a pediatric metachronous adrenocortical tumor.
    Lima Lde O; Lerario AM; Alencar GA; Brito LP; Almeida MQ; Domenice S; Latronico AC; Mendonca BB; Fragoso MC
    Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):72-7. PubMed ID: 21468523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cushing's syndrome in an infant secondary to malignant adrenocortical tumors with somatic mutation of beta-catenin.
    Pusantisampan T; Sangkhathat S; Kayasut K; Kanngurn S; Jaruratanasirikul S; Chotsampancharoen T; Kritsaneepaiboon S
    Pediatr Dev Pathol; 2010; 13(3):238-42. PubMed ID: 19863445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
    Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults.
    Faria AM; Almeida MQ
    Mol Cell Endocrinol; 2012 Mar; 351(1):52-7. PubMed ID: 22019901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
    Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF2 and IGF1R in pediatric adrenocortical tumors: roles in metastasis and steroidogenesis.
    Peixoto Lira RC; Fedatto PF; Marco Antonio DS; Leal LF; Martinelli CE; de Castro M; Tucci S; Neder L; Ramalho L; Seidinger AL; Cardinalli I; Mastellaro MJ; Yunes JA; Brandalise SR; Tone LG; Rauber Antonini SR; Scrideli CA
    Endocr Relat Cancer; 2016 Jun; 23(6):481-93. PubMed ID: 27185872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic landscape of paediatric adrenocortical tumours.
    Pinto EM; Chen X; Easton J; Finkelstein D; Liu Z; Pounds S; Rodriguez-Galindo C; Lund TC; Mardis ER; Wilson RK; Boggs K; Yergeau D; Cheng J; Mulder HL; Manne J; Jenkins J; Mastellaro MJ; Figueiredo BC; Dyer MA; Pappo A; Zhang J; Downing JR; Ribeiro RC; Zambetti GP
    Nat Commun; 2015 Mar; 6():6302. PubMed ID: 25743702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
    Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
    Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous Adrenocortical Carcinoma and Neuroblastoma in an Infant With a Novel Germline p53 Mutation.
    Courtney R; Ranganathan S
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):215-8. PubMed ID: 25374282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.
    Brown TC; Nicolson NG; Korah R; Carling T
    J Am Coll Surg; 2018 Jun; 226(6):988-995. PubMed ID: 29428231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression.
    Wilkin F; Gagné N; Paquette J; Oligny LL; Deal C
    J Clin Endocrinol Metab; 2000 May; 85(5):2048-56. PubMed ID: 10843195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocortical tumors associated with the TP53 p.R337H germline mutation can be identified during child-care consultations.
    Mastellaro MJ; Ribeiro RC; Oliveira-Filho AG; Seidinger AL; Cardinalli IA; Miranda ECM; Aguiar SS; Brandalise SR; Yunes JA; Barros-Filho AA
    J Pediatr (Rio J); 2018; 94(4):432-439. PubMed ID: 28864397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Clinical and Biologic Correlates Associated With Outcome in Children With Adrenocortical Tumors Without Germline TP53 Mutations: A St Jude Adrenocortical Tumor Registry and Children's Oncology Group Study.
    Pinto EM; Rodriguez-Galindo C; Pounds SB; Wang L; Clay MR; Neale G; Garfinkle EAR; Lam CG; Levy CF; Pappo AS; Zambetti GP; Ribeiro RC
    J Clin Oncol; 2017 Dec; 35(35):3956-3963. PubMed ID: 29058986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 germline mutations in adult patients with adrenocortical carcinoma.
    Herrmann LJ; Heinze B; Fassnacht M; Willenberg HS; Quinkler M; Reisch N; Zink M; Allolio B; Hahner S
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E476-85. PubMed ID: 22170717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of CTNNB1 in adrenocortical carcinomas: Identification of novel mutations and correlation to survival.
    Maharjan R; Backman S; Åkerström T; Hellman P; Björklund P
    Sci Rep; 2018 Jun; 8(1):8610. PubMed ID: 29872083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression are not related to clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation.
    Rosati R; Cerrato F; Doghman M; Pianovski MA; Parise GA; Custódio G; Zambetti GP; Ribeiro RC; Riccio A; Figueiredo BC; Lalli E
    Cancer Genet Cytogenet; 2008 Oct; 186(1):19-24. PubMed ID: 18786438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Childhood adrenocortical tumors: from a clinical to a molecular approach].
    Antonini SR; Colli LM; Ferro L; Mermejo L; Castro Md
    Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):599-606. PubMed ID: 22218442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEN1 gene mutation analysis of sporadic adrenocortical lesions.
    Görtz B; Roth J; Speel EJ; Krähenmann A; De Krijger RR; Matias-Guiu X; Muletta-Feurer S; Rütmann K; Saremaslani P; Heitz PU; Komminoth P
    Int J Cancer; 1999 Jan; 80(3):373-9. PubMed ID: 9935177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.